Chelation therapy for treatment of systemic intoxication with uranium: A review

References

• Sumanović-Glamuzina, D.; Saraga-Karacić, V.; Roncević, Z.; Milanov, A.; Bozić, T.; Boranić, M. Incidence of major congenital malformations in a region of Bosnia and Herzegovina allegedly polluted with depleted uranium. Croat. Med. J. 2003, 44(5), 579–584.
   PubMed Web of Science ®Google Scholar
• Busby, C.; Hamdan, M.; Ariabi, E. Cancer, infant mortality and birth sex-ratio in Fallujah, Iraq 2005–2009. Int. J. Environ. Res. Public Health 2010, 7(7), 2828–2837.
   PubMed Web of Science ®Google Scholar
• Alaani, S.; Savabieasfahani, M.; Tafash, M.; Manduca, P. Four polygamous families with congenital birth defects from Fallujah Iraq. Int. J. Environ. Res. Publ. Health 2011, 8(1), 89–96.
   PubMed Web of Science ®Google Scholar
• Lawrence, G.D.; Patel, K.S.; Nusbaum, A. Uranium toxicity and chelation therapy. Pure Appl. Chem. 2014, 86(7), 1105–1110.
   Web of Science ®Google Scholar
• Hare, D.; Tolmachev, S.; James, A.; Bishop, D.; Austin, C.; Fryer, F.; Doble, P. Elemental bio-imaging of thorium, uranium and plutonium in tissues from occupationally exposed former nuclear workers. Anal. Chem. 2010, 82(8), 3176–3182.
   PubMed Web of Science ®Google Scholar
• Figgs, L.W. Lung cancer mortality among uranium gaseous diffusion plant workers: a cohort study 1952–2004. Int. J. Occup. Environ. Med. 2013, 4(3), 128–140.
   Google Scholar
• Zablotska, L.B.; Lane, R.S.; Frost, S.E.; Thompson, P.A. Leukemia, lymphoma and multiple myeloma mortality (1950–1999) and incidence (1969–1999) in the Eldorado uranium workers cohort. Environ. Res. 2014, 130, 43–50.
   PubMed Web of Science ®Google Scholar
• Lenka, P.; Sahoo, S.K.; Mohapatra, S.; Patra, A.C.; Dubey, J.S.; Vidyasagar, D.; Tripathi, R.M.; Puranik, V.D. Ingestion dose from 238U, 232Th, 226Ra, 40K and 137Cs in cereals, pulses and drinking water to adult population in a high background radiation area, Odisha, India. Radiat. Prot. Dosim. 2013, 153(3), 328–333.
   PubMed Web of Science ®Google Scholar
• Larivière, D.; Tolmachev, S.Y.; Kochermin, V.; Johnson, S. Uranium bone content as an indicator of chronic environmental exposure from drinking water. J. Environ. Radioact. 2013, 121, 98–103.
   PubMed Web of Science ®Google Scholar
• Yang, Q.; Smitherman, P.; Hess, C.T.; Culbertson, C.W.; Marvinney, R.G.; Smith, A.E.; Zheng, Y. Uranium and radon in private bedrock well water in Maine: geospatial analysis at two scales. Environ. Sci. Technol. 2014, 48(8), 4298–4306.
   PubMed Web of Science ®Google Scholar
• Frisbie, S.H.; Mitchell, E.J.; Sarkar, B. World Health Organization increases its drinking-water guideline for uranium. Environ. Sci. Proc. Imp. 2013, 10, 1817–1823.
   Google Scholar
• Berisha, F.; Goessler, W. Uranium in Kosovo's drinking water. Chemosphere 2013, 9, 2165–2170.
   Google Scholar
• Arzuaga, X.; Rieth, S.H.; Bathija, A.; Cooper, G.S. Renal effects of exposure to natural and depleted uranium: a review of the epidemiologic and experimental data. J. Toxicol. Environ. Health B Crit. Rev. 2010, 13(7–8), 527–545.
   PubMed Web of Science ®Google Scholar
• Konietzka, R.; Heinze, R.; Seiwert, D.; Dieter, H.H. The ex-vivo intestinal absorption of uranium is a two-phase function of supply. Regul. Toxicol. Pharmacol. 2014, 69(2), 256–262.
   PubMed Web of Science ®Google Scholar
• Konietzka, R. Gastrointestinal absorption of uranium compounds: a review. Regul. Toxicol. Pharmacol. 2015, 71(1), 125–133.
   PubMed Web of Science ®Google Scholar
• Vincente-Vincente, L.; Quiros, Y.; Pérez-Barriocanal, F.; López-Novoa, J.M.; López-Hernández, F.J.; Morales, A.I. Nephrotoxicity of uranium: pathophysiological, diagnostic and therapeutic perspectives. Toxicol. Sci. 2010, 118(2), 324–347.
   PubMed Web of Science ®Google Scholar
• Sutton, M.; Burastero, S.R. Uranium (VI) solubility and speciation in simulated elemental human biological fluids. Chem. Res. Toxicol. 2004, 17, 1468–1480.
   PubMed Web of Science ®Google Scholar
• Kubicki, J.D.; Halada, G.P.; Jha, P.; Phillips, B.L. Quantum mechanical calculation of aqueous uranium complexes: carbonate, phosphate, organic and biomolecular species. Chem. Centr. J. 2009, 3(10), 1–29.
   PubMed Web of Science ®Google Scholar
• Osman, A.A.A.; Geipel, G.; Barkleit, A.; Bernhard, G. Uranium (VI) binding forms in selected body fluids: thermodynamic calculations versus spectroscopic measurements. Chem. Res. Toxicol. 2015, 28(2), 238–247.
   Web of Science ®Google Scholar
• Brendler, V.; Geipel, G.; Bernhard, G.; Nitsche, H. Complexation in the system UO22+/PO43−/OH1−(aq): potentiometric and spectroscopic investigations at very low ionic strengths. Radiochim. Acta 1996, 74, 75–80.
   Web of Science ®Google Scholar
• Smith, T.D. The effect of fluoride ion on the co-ordination of uranium (IV) by ethylenediamine tetraacetic acid. J. Inorg. Nucl. Chem. 1959, 11(4), 314–319.
   Web of Science ®Google Scholar
• Davis, D.G. Polarography of uranium (VI)-EDTA complexes. Anal. Chem. 1961, 33(4), 492–494.
   Web of Science ®Google Scholar
• MacNider, W.D. The inhibition of the toxicity of uranium nitrate by sodium carbonate, and the protection of the kidney acutely nephropathic from uranium from the toxic action of an anesthetic by sodium carbonate. J. Exp. Med. 1916, 23(2), 171–186.
   PubMedGoogle Scholar
• Goto, K. A study of the acidosis, blood urea, and plasma chlorides in uranium nephritis in the dog, and the protective action of sodium bicarbonate. J. Exp. Med. 1917, 25(5), 693–719.
   PubMedGoogle Scholar
• Donnelly, G.L.; Holman, R.L. The stimulating influence of sodium citrate on cellular regeneration and repair in the kidney injured by uranium nitrate. J. Pharmacol. Exp. Ther. 1942, 75, 11–17.
   Google Scholar
• Gustafson, G.E.; Koletsky, S.; Free, A.H. Effect of sodium citrate on uranium poisoning in dogs. Arch. Intern. Med. 1944, 74(6), 416–423.
   Google Scholar
• Haven, F.L.; Randall, C. The urinary excretion of citrate in uranium-poisoned rats. 37th Annual Meeting of the American Society for Pharmacology and Experimental Therapeutics, Chicago, IL, May, 1947. Available at http://www.jbc.org/content/175/2/737.full.pdf (accessed Jun 2015).
   Google Scholar
• Ivannikov, A.T. The effect of the combined administration of diacarb and sodium bicarbonate on the elimination of uranium in various routes of its entry into the organism. Med. Radiol. (Mosk). 1967, 12(8), 63–64.
   Google Scholar
• Dagirmanjian, R.; Maynard, E.A.; Hodge, H.C. The effects of calcium disodium ethylenediamine tetraacetate on uranium poisoning in rats. J. Pharmacol. Exp. Ther. 1956, 117(1), 20–28.
   PubMed Web of Science ®Google Scholar
• Tse, M.-L. Antidotal treatment for radioactive materials. Hong Kong Med. Diary 2011, 16(4), 32–33.
   Google Scholar
• Smith, S.W. The role of chelation in the treatment of other metal poisonings. J. Med. Toxicol. 2013, 9(4), 335–369.
   Google Scholar
• Ortega, A.; Domingo, J.L.; Gómez, M.; Corbella, J. Treatment of experimental acute uranium poisoning by chelating agents. Pharmacol. Toxicol. 1989, 64(3), 247–251.
   PubMedGoogle Scholar
• Domingo, J.L.; Ortega, A.; Llobet, J.M.; Corbella, J. Effectiveness of chelation therapy with time after acute uranium intoxication. Fund. Appl. Toxicol. 1990, 14(1), 88–95.
   PubMedGoogle Scholar
• Hengé-Napolie, M.H.; Ansoborlo, E.; Houpert, P.; Mirto, H.; Paquet, F.; Burgada, R.; Hodgson, R.; Stradling, G.N. Progress and trends in in vivo chelation of uranium. Radiat. Prot. Dosim. 1998, 79(1–4), 449–452.
   Web of Science ®Google Scholar
• Durbin, P.W.; Kullgren, B.; Xu, J.; Raymond, K.N. New agents for in vivo chelation of uranium (VI): efficacy and toxicity in mice of multidentate catecholate and hydroxypyridinonate ligands. Health Phys. 1997, 72(6), 865–878.
   PubMed Web of Science ®Google Scholar
• Durbin, P.W.; Kullgren, B.; Ebbe, S.N.; Xu, J.; Raymond, K.N. Chelating agents for uranium (VI): 2. efficacy and toxicity of tetradentate catecholate and hydroxypyridinonate ligands in mice. Health Phys. 2000, 78(5), 511–521.
   PubMed Web of Science ®Google Scholar
• Szigethy. G.; Raymond, K.N. Designing the ideal uranyl-ligand: a sterically-induced speciation change in complexes with thiophene-bridged bis(3-hydroxy-N-methyl-pyridine-2-one. Inorg. Chem. 2009, 48(24), 11489–11491.
   PubMed Web of Science ®Google Scholar
• Ni, C.; Shuh, D.K.; Raymond, K.N. Uranyl sequestration: synthesis and structural characterization of uranyl complexes with a tetradentate methylterephthalamide ligand. Chem. Comunic. (Camb.) 2011, 47(22), 6392–6394.
   PubMed Web of Science ®Google Scholar
• Abergel, R.J.; Durbin, P.W.; Kullgren, B.; Ebbe, S.N.; Xu, J.; Chang, P.Y.; Bunin, D.I.; Blakely, E.A.; Bjornstad, K.A.; Rosen, C.J.; Shuh, D.K.; Raymond, K.N. Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-2,3-HOPO). Health Phys. 2010, 99(3), 401–407.
   PubMed Web of Science ®Google Scholar
• Bunin, D.I.; Chang, P.Y.; Doppalapudi, R.S.; Riccio, E.S.; An, D.; Jarvis, E.E.; Kullgren, B.; Abergel, R.J. Dose-dependent efficacy and safety toxicology of hydroxypyridinoate actinide decorporation agents in rodents: towards a safe and effective human dosing regimen. Radiat. Res. 2013, 179(2), 171–182.
   PubMed Web of Science ®Google Scholar
• Kullgren, B.; Jarvis, E.E.; An, D.D.; Abergel, R.J. Actinide chelation: biodistribution and in vivo complex stability of the targeted metal ions. Toxicol. Mech. Meth. 2013, 23(1), 18–26.
   PubMed Web of Science ®Google Scholar
• Fukuda, S. Chelating agents used for plutonium and uranium removal in radiation emergency medicine. Curr. Med. Chem. 2005, 12(23), 2765–2770.
   PubMed Web of Science ®Google Scholar
• Fukuda, S.; Ikeda, M.; Nakamura, M.; Yan, X.; Xie, Y. Efficacy of oral and intraperitoneal administration of CBMIDA for removing uranium in rats after parenteral injections of depleted uranium. Radiat. Prot. Dosim. 2009, 133(1), 12–19.
   PubMed Web of Science ®Google Scholar
• Zhuo, W.; Chen, H.; Chen, B.; Liu, H. A brief review of researches related to radiation emergency medicine at Fudan University, China. Rad. Emerg. Med. 2012, 1(1–2), 7–10.
   Google Scholar
• Montavon, G.; Repinc, U.; Apostolidis, C.; Bruchertseifer, F.; Abbas, K.; Morgenstern, A. Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for (230)U. Dalton Trans. 2010, 39(5), 1366–1374.
   PubMed Web of Science ®Google Scholar
• Markich, S.J. Uranium speciation and bioavailability in aquatic systems: an overview. Scient. World J. 2002, 2, 707–729.
   Google Scholar
• Majumdar, D.; Roszak, S.; Balasubramanian, K.; Nitsche, H. Theoretical study of aqueous uranyl carbonate (UO2CO3)×nH2O (n=1–3). Chem. Phys. Lett. 2003, 372(1–2), 232–241.
   Web of Science ®Google Scholar
• Bergeron, R.J.; Wiegand, J.; Singh, S. Desferrithiocin analogue decorporation agents. Int. J. Radiat. Biol. 2009, 85(4), 348–361.
   PubMed Web of Science ®Google Scholar
• Sawicki, M.; Lecerclé, D.; Grillon, G.; Le Gall, B.; Sérandour, A.L.; Poncy, J.L.; Bailly, T.; Burgada, R.; Lecouvey, M.; Challeix, V.; Leydier, A.; Pellet-Rostaing, S.; Ansoborlo, E.; Taran, F. Bisphosphonate sequestering agents. Synthesis and preliminary evaluation for in vitro and in vivo uranium (VI) chelation. Eur. J. Med. Chem. 2008, 43(12), 2768–2777.
   PubMed Web of Science ®Google Scholar
• Liu, G.; Men, P.; Kenner, G. 1-(2-hydroxyethoxy)methyl-2-methyl-3-hydroxyl-4-pyridinone: a targeted, bifunctional chelating agent for potential uranic detoxification in the kidney. Hemoglobin 2011, 35(3), 291–300.
   PubMed Web of Science ®Google Scholar
• Bao, Y.; Wang, D.; Li, Z.; Hu, Y.; Xu, A.; Wang, Q.; Shao, C.; Chen, H. Efficacy of a novel chelator BPCBG for removing uranium and protecting against uranium-induced renal cell damage in rats and HK-2 cells. Toxicol. Appl. Pharmacol. 2013, 269(1), 17–24.
   PubMed Web of Science ®Google Scholar
• U.S. FDA. package insert–instructions for use. Available at http://www.fda.gov/drugs/emergencypreparedness/bioterrorismanddrugpreparedness/ucm130314.htm (assessed Mar 2014).
   Google Scholar
• Inczédy, J. Analytical Applications of Complex Equilibria, Ellis Horwood Series in Analytical Chemistry, Ellis Horwood, Ltd., Chichester, UK, 1976; 317–368.
   Google Scholar
• Günther, A.; Steudtner, R.; Schmeide, K.; Bernhard, G. Luminescence properties of uranium (VI) citrate and uranium (VI) oxalate species and their application in the determination of complex formation constants. Radiochim. Acta 2011, 99(9), 535−541.
   Web of Science ®Google Scholar
• Günther, A.; Geipel, G.; Bernhard, G. Complex formation of uranium (VI) with the amino acids L-glycine and L-cystine: A fluorescence emission and UV-Vis absorption study. Polyhedron 2007, 26(1), 59–65.
   Web of Science ®Google Scholar
• Osman, A.A.A.; Geipel, G.; Bernhard, G. Interaction of uranium (VI) with bioligands present in human biological fluids: the case study of urea and uric acid. Radiochim. Acta 2013, 101(3), 139–147.
   Web of Science ®Google Scholar